Hyderabad Telangana, India

Chandrasekhar Abbineni

This inventor holds 6 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Orion Corporation, Aurigene Discovery Technologies Limited, Aurigene Oncology Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chandrasekhar Abbineni. Retrieved from https://idiyas.com/inventor/chandrasekhar-abbineni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Chandrasekhar Abbineni: Innovator in Pharmaceutical Chemistry

Introduction

Chandrasekhar Abbineni is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 6 patents to his name, Abbineni's work is paving the way for advancements in medical treatments.

Latest Patents

Abbineni's latest patents include innovative compounds that target specific biological pathways. One of his notable inventions is the development of pyridazine derivatives as SMARCA2/4 degraders. This invention provides pyridazine derivatives of formula (I), which are therapeutically useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2/4 in mammals. The invention also details the preparation of these compounds and pharmaceutical compositions comprising at least one of the pyridazine derivatives or a pharmaceutically acceptable salt, or a stereoisomer thereof. Another significant patent involves small molecule inhibitors of TEAD transcription factors. These compounds inhibit the activity of the TEAD transcription factor and are useful in treating diseases related to its activity, including cancer and other disorders.

Career Highlights

Throughout his career, Abbineni has worked with reputable organizations, including Orion Corporation and The General Hospital Corporation. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.

Collaborations

Abbineni has collaborated with several professionals in his field, including Susanta Samajdar and Sanjita Sasmal. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Chandrasekhar Abbineni is a distinguished inventor whose work in pharmaceutical chemistry is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…